Skip to content
Buy This GLP
← Research
Evidence

Do GLP-1 Drugs Help You Quit Smoking? What Trials Found

Earlier trials did not establish higher quit rates. A 2026 semaglutide trial found lower craving and no clear improvement in smoking behavior.

Editorial profile: Wesley JenkinsBuy This GLP Editorial Team4 min read
Odds of quitting, pooled across two trials1.0, no difference0.553.351.36

The available trials have not established GLP-1 drugs as a way to quit smoking. As in GLP-1 studies for opioid use disorder, researchers measure cravings and actual substance use separately. An improvement in craving alone does not show that more people quit.[1][2]

What the quit-smoking trials found

A review that searched for studies through November 2025 pooled 337 analyzed participants from two randomized trials. The odds ratio for quitting was 1.36 (95% CI 0.55–3.35). The interval includes the possibility of lower or higher odds with treatment, and the authors rated the evidence very low certainty.[1]

In the smaller pilot, 46.3% of people receiving exenatide were abstinent at six weeks compared with 26.8% receiving placebo. Both groups used nicotine patches and counseling. The estimate was uncertain (risk ratio 1.70, 95% credible interval 0.96–3.27). In the larger trial, abstinence at 12 weeks was 63% with dulaglutide and 65% with placebo. Both groups received varenicline and counseling.[3][4]

What the semaglutide trial added

A 2026 laboratory study randomized 24 adults who smoked daily, and 21 completed the primary outcome assessment. Semaglutide did not significantly improve participants’ ability to delay smoking in the laboratory or reduce cigarettes smoked per day in weekly reports. Participants assigned semaglutide did report lower nicotine craving on some measures. The trial was designed to measure smoking behavior and craving during treatment rather than sustained abstinence.[2]

Weight is a separate outcome

The earlier review found lower post-cessation weight with GLP-1 drugs than with controls. That comparison addresses weight change during a quit attempt. It cannot show whether the lower weight helped people stay smoke-free.[1]

Frequently asked

Has semaglutide been shown to help people quit smoking?
A small 2026 trial reported lower craving with semaglutide and no clear improvement in laboratory smoking resistance or weekly cigarette consumption. It did not establish an effect on lasting abstinence.
What treatments have evidence for quitting smoking?
The CDC recommends counseling and approved medications such as nicotine replacement, varenicline, and bupropion.

Sources

  1. [1] Heshmati J, Mahmoodianfard S, Raizman E, Abraham A, Mir H (2026). GLP-1 agonists for smoking cessation and post-cessation weight management: A systematic review and meta-analysis of randomized trials Tobacco Induced Diseases. PMID 42529623
  2. [2] Hendershot CS, Bremmer MP, Paladino MB, et al. (2026). Once-Weekly Semaglutide in Adults With Daily Cigarette Use: A Randomized Clinical Trial JAMA Network Open. PMID 42189538
  3. [3] Yammine L, Green CE, Kosten TR, et al. (2021). Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial Nicotine & Tobacco Research. PMID 33831213
  4. [4] Lengsfeld S, et al. (2023). Effect of dulaglutide in promoting abstinence during smoking cessation: a single-centre, randomized, double-blind, placebo-controlled, parallel group trial eClinicalMedicine. Source
  5. [5] Centers for Disease Control and Prevention (2024). How to Quit Smoking CDC. Source

Where to get it

Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

Open the price desk →

More in Evidence